1st Quarter - Report — OMNICARE, INC. for OMNICARE INC (2014)

Firm

OMNICARE, INC.

Client

OMNICARE INC

Income

—

Expenses

$200,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Federal auditing standards of downstream Medicare drug benefit plan sponsors; Medicare Part D reimbursement; Reimbursement for prescription drugs for hospice patients; Medicare proposed Part D Rule

Lobbyist	Covered position, as disclosed
JAMES FLOOD	—
ELIZABETH TERRY	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Drug Enforcement Administration (DEA); SENATE; Health & Human Services, Dept of (HHS)

Pharmacy PHA

Drug Enforcement Administration proposed rule on disposal of controlled substances in long term care facilities; Reclassification of hydrocodone-containing prescription drugs from Schedule III to Schedule II drugs

Lobbyist	Covered position, as disclosed
JAMES FLOOD	—
ELIZABETH TERRY	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); Office of Management & Budget (OMB); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.